Taysha Gene Therapies' Nagendran Sukumar makes significant buys and sells of shares.

Taysha Gene Therapies, Inc. [TSHA] recently disclosed that Director, President, and Head of R&D Nagendran Sukumar engaged in various transactions involving the company's shares. Specifically, on November 28, 2025, Sukumar acquired 70,172 shares at a price of $0.7 per share. On the same day, he sold 110,125 shares at $4.75 per share. Additionally, on December 1, 2025, Sukumar sold 260,047 shares at $4.51 per share and purchased 260,047 shares at $1.71 per share. Furthermore, he purchased 39,953 shares at $1.71 per share on November 28, 2025. These transactions highlight Sukumar's continued involvement in the company and his confidence in its future prospects.